NFKB1 and acute kidney injury: CASC2 inhibited inflammation, apoptosis, and oxidative stress by negatively regulating miR-155 and NF-κB pathways, thus suggesting that CASC2 could serve as a potential target for treating SA-AKI (Wang et al., 2020d).